EP2601949
Lyfjasamsetningar með (1S)-1,5-anhýdró-1-[5-(4-etoxýbensýl)-2-metoxý-4-metýlfenýl]-1-þíó-D-glúkítóli og insúlínseytingarörva
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
16.4.2010EP published:
29.10.2014EP application number:
13157571.4
EP translation filed:
13.1.2015Grant published:
15.2.2015EPO information:
European Patent Register
Max expiry date:
15.4.2030Expiry date:
15.4.2017
Title:
Pharmaceutical compositions with (1S)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol and an insulin secretagogue.
Timeline
Today
16.4.2010EP application
29.10.2014EP Publication
13.1.2015Translation submitted
15.2.2015Registration published
15.4.2017Expires
Owner
Name:
Taisho Pharmaceutical Co., Ltd.Address:
24-1 Takada 3-chome Toshima-ku, 170-8633, Tokyo, JP
Inventor
Name:
Takahashi, TeisukeAddress:
Tokyo,, JP
Name:
Uchida, SaekoAddress:
Tokyo,, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2009100210Date:
16.4.2009Country:
JP
Classification
Categories:
A61K 31/382, A61K 31/155, A61K 31/4439, A61K 31/64, A61K 45/00, A61P 3/10, A61P 5/50, A61P 9/10, A61P 9/14, A61P 13/12, A61P 25/00, A61P 27/02, A61P 43/00, C07D 335/02
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 27.4.2015
Expires: 15.4.2016
Payer: Árnason Faktor
Number: 7
Paid: 22.3.2016
Expires: 15.4.2017
Payer: G. H. Sigurgeirsson